IMC Chicago’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
23,080
-39,134
| -63% | -$1.9M | ﹤0.01% | 344 |
|
|
2025
Q1 | $2.12M | Sell |
62,214
-24,255
| -28% | -$825K | ﹤0.01% | 180 |
|
|
2024
Q4 | $3.4M | Buy |
+86,469
| New | +$3.4M | ﹤0.01% | 137 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 668 |
|
|
2024
Q2 | – | Sell |
-36,722
| Closed | -$2.5M | – | 723 |
|
|
2024
Q1 | $2.5M | Sell |
36,722
-1,495
| -4% | -$102K | ﹤0.01% | 107 |
|
|
2023
Q4 | $2.39M | Buy |
38,217
+6,914
| +22% | +$433K | ﹤0.01% | 80 |
|
|
2023
Q3 | $1.42M | Buy |
31,303
+15,640
| +100% | +$710K | ﹤0.01% | 100 |
|
|
2023
Q2 | $879K | Buy |
15,663
+1,731
| +12% | +$97.2K | ﹤0.01% | 102 |
|
|
2023
Q1 | $630K | Sell |
13,932
-6,974
| -33% | -$315K | ﹤0.01% | 131 |
|
|
2022
Q4 | $850K | Buy |
+20,906
| New | +$850K | ﹤0.01% | 99 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 297 |
|
|
2022
Q2 | – | Sell |
-21,994
| Closed | -$1.38M | – | 283 |
|
|
2022
Q1 | $1.38M | Sell |
21,994
-24,086
| -52% | -$1.51M | ﹤0.01% | 121 |
|
|
2021
Q4 | $3.49M | Buy |
46,080
+18,036
| +64% | +$1.37M | ﹤0.01% | 73 |
|
|
2021
Q3 | $3.14M | Buy |
28,044
+15,291
| +120% | +$1.71M | ﹤0.01% | 67 |
|
|
2021
Q2 | $2.07M | Sell |
12,753
-7,667
| -38% | -$1.24M | ﹤0.01% | 76 |
|
|
2021
Q1 | $2.49M | Buy |
+20,420
| New | +$2.49M | ﹤0.01% | 77 |
|